In the qualification of medical-grade impact copolymer polypropylene contacted with parenteral fluids, wound exudate, or respiratory condensate, the regulatory status of the base polymer under 21 CFR 177.1520(c) is often evaluated alongside chemical characterization performed according to ISO 10993-18:2020 clause 8 and leachables risk assessment under ISO 10993-17:2002. The term “extractables testing” in this context denotes the analytical determination of organic and inorganic species that migrate from the polymer matrix under exaggerated solvent, temperature, and time conditions, whereas “leachables” denotes species released under simulated clinical use. 21 CFR 177.1520(c) is a food-contact specification for olefin polymers, not a medical device biocompatibility endpoint; nevertheless, its gravimetric total extractable fraction limits provide a raw-material purity benchmark that has been incorporated into numerous master batch and finished-component acceptance criteria for copolymer polypropylene used in syringes, surgical stapler housings, sharps containers, and IV connectors. Impact copolymer polypropylene of the type typically assigned to this regulation is a heterophasic resin manufactured by sequential propylene homopolymerization followed by ethylene-propylene rubber copolymerization, yielding an ethylene comonomer content in the 4–12 wt% range, a matrix isotacticity sufficient to maintain a density of 0.895–0.905 g/cm³ when measured by ISO 1183-1:2019, and a melt flow rate in the 8–25 g/10 min range at 230 °C/2.16 kg per ISO 1133-1:2022. Because the ethylene-propylene rubber phase is selectively soluble in hot xylene, total extractable fraction testing under this regulation distinguishes low-molecular-weight additive and oligomer pools from the higher-molecular-weight elastomeric fraction, and failure to control extraction temperature, time, and solvent purity can produce gravimetric residues that exceed the applicable specification even when the finished component is suitable for its intended medical application.

What Extraction Conditions Satisfy Paragraph (c) Gravimetric Specifications for Impact Copolymer Polypropylene?

The gravimetric extraction procedure historically associated with 21 CFR 177.1520(c) uses two solvents with markedly different solvency for polypropylene: n-hexane at reflux, approximately 68–69 °C, and xylene at reflux, approximately 138–142 °C. Samples are converted to a high-surface-area form by cryogenic grinding with liquid nitrogen to pass a 0.5–1.0 mm sieve or by compression molding into 0.2–0.5 mm films; the selected form must be representative of the finished polymer phase, and any additive-rich skin surface generated by injection molding should be documented because skin-core heterogeneity can alter the measured extractable fraction. For n-hexane extraction, the ground polymer is refluxed for 2 h in a round-bottom flask fitted with a water-cooled condenser, after which the suspension is filtered through a preweighed glass-fiber filter with 0.7–1.2 µm porosity, and the filtrate is evaporated in a tared aluminum or glass dish under a filtered nitrogen stream at 40–60 °C. The residue is dried to constant mass at 105 °C for 2 h, cooled in a desiccator over fresh silica gel for 30 min, and weighed on a balance with 0.1 mg readability. Xylene extraction follows the same gravimetric sequence but requires a higher evaporation temperature, typically 140–150 °C under vacuum, because xylene has a boiling point of 138–142 °C and a relatively low vapor pressure at room temperature; incomplete removal of xylene produces a false-positive extractable fraction. For polypropylene homopolymer and copolymer grades covered by the regulation, the commonly applied gravimetric limits are 6.4 wt% in n-hexane and 30 wt% in xylene; however, the current eCFR text should be checked because Federal Register amendments may adjust polymer-type-specific values. When accelerated solvent extraction is substituted for reflux, a stainless-steel extraction cell of 22 mL or 34 mL operated at 100–125 °C and 100–150 bar with two static cycles of 10 min each can produce equivalent n-hexane extractable fractions, but the substitution must be validated against reflux extraction because the elevated pressure and temperature can swell the elastomer phase and extract additional low-molecular-weight ethylene-propylene rubber.

Because additive extraction, rather than base-polymer dissolution, dominates the n-hexane extractable fraction in impact copolymer polypropylene, a parallel qualitative and quantitative extractables screen is required to assign gravimetric residues to specific chemical species. Medical-grade copolymer polypropylene stabilized for gamma irradiation or autoclave service typically contains a primary hindered phenolic antioxidant at 0.02–0.10 wt%, a secondary phosphite process stabilizer at 0.05–0.15 wt%, an acid neutralizer at 0.01–0.10 wt%, a slip agent at 0.05–0.20 wt%, and a nucleator at 0.05–0.20 wt%, depending on the required crystallization rate and optical clarity. Each additive class contributes both the parent compound and transformation products to the total extractable fraction; the phosphite stabilizer tris(2,4-di-tert-butylphenyl) phosphite, CAS 31570-04-4, is hydrolytically unstable in aqueous simulants and is quantified alongside its oxidized tris(2,4-di-tert-butylphenyl) phosphate, CAS 95906-11-9, while the hindered phenolic antioxidant pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate), CAS 6683-19-8, generates low-molecular-weight phenolic scission products under gamma irradiation. The table below lists representative extractables for a copolymer polypropylene formulation; concentrations are typical raw-material loading ranges, not measured migration values, and the analytical methods reflect common quantitative approaches in medical device chemical characterization.

Thermal Oxidation By-Products of Hindered Phenol/Phosphite Stabilizer Systems Under Autoclave and Soxhlet Extraction

Extractable profiles reported for impact copolymer polypropylene after repetitive autoclave conditioning at 121 °C for 1 h in purified water differ from those obtained by Soxhlet extraction in n-hexane because water promotes hydrolysis of the phosphite stabilizer and hydrolysis-derived phenols, while n-hexane extracts intact stabilizers and nonpolar oligomers. The mechanistic sequence for the secondary phosphite antioxidant involves hydroperoxide reduction to the corresponding alcohol and oxidation of tris(2,4-di-tert-butylphenyl) phosphite to tris(2,4-di-tert-butylphenyl) phosphate; under humid thermal stress the phosphate can hydrolyze to bis(2,4-di-tert-butylphenyl) hydrogen phosphate and free 2,4-di-tert-butylphenol, the latter being sufficiently volatile for headspace gas chromatography at 80 °C incubation with a split injection flow of 20:1. The hindered phenolic primary antioxidant operates by hydrogen-atom transfer to peroxyl radicals and yields quinoidal oxidation products that are best resolved by reversed-phase LC-QTOF-MS using a C18 column of 100 mm × 2.1 mm, 1.7 µm particle size, with mobile phase 0.1% formic acid in water and acetonitrile, and quantification against a certified analytical standard with exact mass error <5 ppm. For autoclave-exposed films, the extraction ratio specified by ISO 10993-12:2021 for polymer components is 3 cm²/mL or 0.1 g/mL when surface area cannot be calculated; extraction at 121 °C for 1 h is aggressive and can overestimate clinical leachables for devices with only brief contact, but it is intentionally conservative for materials that may be exposed to steam sterilization in hospital processing. Because gravimetric methods cannot distinguish a toxicologically relevant degradation product from a non-hazardous oligomer, each signal above the analytical evaluation threshold derived from ISO 10993-18:2020 should be identified by tandem mass spectrometry and reported with retention time, accurate mass, and proposed structure; if a signal cannot be identified below 5 ppm mass error, published data for this specific configuration is limited and the result should be reported as an unidentified extractable with conservative toxicological assumptions.

When Solvent Polarity Shifts Extractable Profiles: Non-Polar n-Hexane Reflux Versus Aqueous-Organic Simulant Extraction

Comparison of n-hexane and xylene gravimetric extractable fractions with aqueous-organic simulant extracts demonstrates that total extractable mass is a poor predictor of the biological surface burden of a medical device made from copolymer polypropylene. Under ISO 10993-12:2021, exhaustive extraction in purified water, 0.9% sodium chloride, 10% ethanol/water v/v, and 95% ethanol/water v/v at temperatures of 37 °C for 72 h, 50 °C for 72 h, 70 °C for 24 h, or 121 °C for 1 h yields far lower total organic carbon values than n-hexane reflux but can solubilize polar antioxidant degradation products, catalyst-derived chloride, and acid neutralizer residues that are not captured by gravimetric n-hexane extraction. A lipophilic slip agent such as erucamide partitions strongly into 95% ethanol/water and n-hexane, while hydrated calcium stearate or sodium benzoate residues partition into aqueous simulants; therefore a compliance strategy limited to 21 CFR 177.1520(c) gravimetric extraction can miss high-polarity leachables. The analytical evaluation threshold for individual organic extractables is calculated by dividing the allowable toxicological concern dose by the number of devices per patient per day and the extraction ratio; when the systemic lifetime TTC of 1.5 µg/day is used for a single device extracted into 10 mL of solvent, the resulting AET is 0.15 µg/mL, but clinical use and exposure duration can alter this threshold by orders of magnitude. Laboratories should therefore run both the gravimetric food-contact extraction and the analytical chemical characterization in parallel, with the gravimetric result used as a raw-material purity check and the analytical result used for toxicological risk assessment under ISO 10993-18:2020 clause 7 and ISO 10993-17:2002.

Quantitative instrumental analysis of the extraction residues begins with sample preparation that preserves volatile and thermally labile species and avoids evaporative losses of n-hexane-extractable oligomers. For volatile and semivolatile extractables, a headspace sampler operated at 80 °C for 30 min with a loop temperature of 110 °C and transfer line at 120 °C is coupled to a gas chromatograph–mass spectrometer equipped with a 60 m × 0.32 mm, 1.8 µm DB-624 column and mass spectral scan range m/z 33–550; this configuration resolves residual hexane, 2,4-di-tert-butylphenol, and siloxane contaminants from silicone tubing or syringe seals. Nonvolatile organic extractables are analyzed by reversed-phase LC-QTOF-MS with electrospray ionization in positive and negative modes, using a 100 mm × 2.1 mm, 1.7 µm C18 column, mobile phase 10 mM ammonium formate in water and acetonitrile, and a resolving power of at least 30,000 FWHM; collision-induced dissociation spectra are acquired in data-dependent acquisition with a normalized collision energy ramp of 15–40 eV. Metal extractables originating from Ziegler-Natta catalyst residues, processing equipment wear, or external contamination are determined by inductively coupled plasma mass spectrometry after microwave-assisted acid digestion with nitric acid and hydrogen peroxide in closed fluoropolymer vessels heated to 180 °C for 25 min; elements routinely monitored include magnesium, aluminum, titanium, chromium, nickel, copper, zinc, arsenic, cadmium, lead, and mercury, with limits of quantitation in the 0.01–0.1 µg/g polymer range depending on isotope abundance and interference. Method validation for all quantitative extractables procedures follows USP <1663> for study design and USP <1664> for leachables analysis, with linearity demonstrated over a minimum of five calibration levels, correlation coefficient R² ≥ 0.995, recovery 70–120% at three spiked levels, and repeatability expressed as relative standard deviation ≤15% at the lower limit of quantitation. The instrument sequence includes solvent blanks, procedural blanks, matrix blanks, and continuing calibration verification every 20 injections; any carryover above 0.1% of the previous injection peak area triggers needle wash and blank re-injection before proceeding.

Mechanical Property Retention and Extractable Fraction Correlation in Impact Copolymer Polypropylene

Rheological and mechanical properties of impact copolymer polypropylene are not independent of extractable fraction because the same low-molecular-weight chains that contribute to n-hexane extractables also affect crystal nucleation, impact strength, and long-term oxidative stability. Melt flow rate measured at 230 °C under 2.16 kg load according to ISO 1133-1:2022 is typically 10–25 g/10 min for medical injection-molding grades; lower-molecular-weight chain populations increase both MFR and n-hexane extractable fraction, but an inverse linear relationship should not be assumed because additive loadings can dominate gravimetric extractables. Tensile yield stress determined by ASTM D638-14 at 50 mm/min on Type IV specimens is commonly 20–25 MPa for impact copolymer polypropylene with 6–12% ethylene comonomer, while notched Izod impact at 23 °C per ASTM D256-10 ranges from 150 J/m to 400 J/m depending on elastomer phase particle size and dispersed phase molecular weight. Flexural modulus by ASTM D790-17 is commonly 800–1200 MPa. The xylene-soluble fraction, which is related to the ethylene-propylene rubber phase, increases with rubber content and can exceed the gravimetric xylene extractable fraction limit in the current eCFR text if the elastomer phase is not sufficiently high in molecular weight; this is a known manufacturing control point for copolymer polypropylene intended for food-contact or medical use. Because additive-rich surface layers can form during injection molding due to mold temperature gradients and flow-induced segregation, mechanical test plaques and extraction films should be prepared under identical thermal and shear histories; otherwise the extractable fraction of a plaque with a skin layer will not represent the bulk resin, and a finished component may pass mechanical specifications while still failing gravimetric extractable fraction requirements.

Extruder and injection-molding thermal histories alter the oligomer distribution and therefore the extractable-fraction result before any clinically relevant exposure occurs. Twin-screw compounding of copolymer polypropylene with additive masterbatches is performed on co-rotating intermeshing screws with length-to-diameter ratio of 36–48, barrel temperatures from 180 °C at the feed throat to 230 °C at the die, screw speeds of 200–400 rpm, and specific mechanical energy inputs of 0.15–0.25 kWh/kg; extended residence time above 230 °C promotes chain scission, increases the low-molecular-weight isotactic polypropylene fraction, and raises n-hexane extractables. Injection molding of medical components uses melt temperatures of 200–250 °C, mold temperatures of 20–60 °C, injection pressures of 800–1200 bar, and clamp forces selected for the projected area at 40–80 MPa cavity pressure; gate freeze-off and orientation-induced crystallization create a skin-core morphology with lower additive concentration in the core and higher slip-agent concentration at the surface. Pregranulated resin stored at relative humidity above 60% should be dried in a desiccant dryer at 80 °C for 2–4 h to a dew point below -40 °C because free moisture reacts with phosphite stabilizers during melting and generates phenolic extractables. Gamma irradiation at doses of 25–50 kGy according to ISO 11137-1:2006/A1:2013 produces alkyl radicals that react with dissolved oxygen to form ketones, carboxylic acids, and chain-end unsaturation; these oxidative species increase polar extractables in aqueous simulants and can consume the hindered phenolic antioxidant, while ethylene oxide sterilization per ISO 11135:2014 adds potential ethylene oxide and ethylene chlorohydrin residues that must be quantified under ISO 10993-7:2008 and are not part of 21 CFR 177.1520(c) gravimetric extraction.

Does Sterilization Irradiation Produce Additional Extractable Species That Require Paragraph (c) Re-Evaluation?

Radiation-sterilized impact copolymer polypropylene can exhibit an extractables profile that differs from the virgin resin because 25–50 kGy gamma or electron-beam irradiation induces molecular scission and oxidative modification of both the isotactic polypropylene matrix and the ethylene-propylene rubber phase. The resulting low-molecular-weight products include terminal alkenes, ketones, hydroperoxides, and carboxylic acids; these polar species are poorly represented in n-hexane gravimetric extractable fraction but are detected in 10% ethanol/water and aqueous simulants by hydrophilic-interaction liquid chromatography or ion chromatography. If the gravimetric n-hexane extractable fraction is measured only before sterilization, the value will not reflect the sterilized finished device; therefore stability-indicating extraction studies should include an irradiation challenge followed by solvent extraction of the irradiated component within 30 days to capture post-irradiation radical decay. Electron spin resonance can confirm trapped free radicals in the crystalline phase after irradiation, but routine quality control is more likely to use headspace GC-MS for volatile ketones and LC-MS/MS for oxidation products. The applicable acceptance criterion remains the gravimetric limit in the current 21 CFR 177.1520(c) paragraph, but because that criterion is not a biological safety limit, any new extractable above the analytical evaluation threshold must be assessed according to ISO 10993-18:2020 and ISO 10993-17:2002; if the sterilized material exceeds the gravimetric limit due to irradiation-induced oligomer formation, antioxidant loading and irradiation atmosphere should be reviewed before changing the base polymer grade.

An extractables testing program for a medical device copolymer polypropylene component under 21 CFR 177.1520(c) is documented through a compliance matrix that links each specification to an analytical method, instrument type, and acceptance criterion. The following matrix represents a typical chemical characterization and gravimetric extractables program for an impact copolymer polypropylene component with a patient-contacting surface area below 100 cm² and a single-device-per-day exposure assumption.